|
1
|
Kaniewska M, Eder P, Gąsiorowska A,
Gonciarz M, Kierkuś J, Małecka-Panas E and Rydzewska G: Biosimilar
biological drugs in the treatment of inflammatory bowel diseases.
Prz Gastroenterol. 14:223–227. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Greenwood-Van Meerveld B: Intestinal
barrier function in health and gastrointestinal disease: Review
Article. Neurogastroenterol Motil. 24(889)2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Spalinger MR, Sayoc-Becerra A,
Ordookhanian C, Canale V, Santos AN, King SJ, Krishnan M, Nair MG,
Scharl M and McCole DF: The JAK inhibitor tofacitinib rescues
intestinal barrier defects caused by disrupted
epithelial-macrophage interactions. J Crohns Colitis. 15:471–484.
2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Du L and Ha C: Epidemiology and
pathogenesis of ulcerative colitis. Gastroenterol Clin North Am.
49:643–654. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Pilarczyk-Zurek M, Strus M, Adamski P and
Heczko PB: The dual role of Escherichia coli in the course of
ulcerative colitis. BMC Gastroenterol. 16(128)2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ordás I, Eckmann L, Talamini M, Baumgart
DC and Sandborn WJ: Ulcerative colitis. Lancet. 380:1606–1619.
2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Strober W: Trypan blue exclusion test of
cell viability. Curr Protoc Immunol Appendix 3: Appendix 3B,
2001.
|
|
8
|
Buranaamnuay K: The MTT assay application
to measure the viability of spermatozoa: A variety of the assay
protocols. Open Vet J. 11:251–269. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kurien BT and Hal Scofield R: Western
blotting: Methods and protocols. West Blotting Methods Protoc.
1312:1–509. 2015.
|
|
10
|
Bułdak Ł, Skudrzyk E, Machnik G, Bołdys A,
Bułdak RJ and Okopień B: Exenatide improves antioxidant capacity
and reduces the expression of LDL receptors and PCSK9 in human
insulin-secreting 1.1E7 cell line subjected to hyperglycemia and
oxidative stress. Postepy Hig Med Dosw. 76:16–23. 2022.
|
|
11
|
Bourne R and Bourne R: ImageJ. Fundam
Digit Imaging Med. 9:185–188. 2010.
|
|
12
|
Machnik G, Łabuzek K, Skudrzyk E, Rekowski
P, Ruczyński J, Wojciechowska M, Mucha P, Giri S and Okopień B: A
peptide nucleic acid (PNA)-mediated polymerase chain reaction
clamping allows the selective inhibition of the ERVWE1 gene
amplification. Mol Cell Probes. 28:237–241. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)). Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zihni C, Mills C, Matter K and Balda MS:
Tight junctions: From simple barriers to multifunctional molecular
gates. Nat Rev Mol Cell Biol. 17:564–580. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yang J and Xie X: Tofacitinib protects
intestinal epithelial cells against oxygen-glucose
deprivation/reoxygenation injury by inhibiting the JAK/STAT3
signaling pathway. Exp Ther Med. 22(1108)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zuo J, Zhao M, Liu B, Han X, Li Y, Wang W,
Zhang Q, Lv P, Xing L, Shen H and Zhang X: TNF-α-mediated
upregulation of SOD-2 contributes to cell proliferation and
cisplatin resistance in esophageal squamous cell carcinoma. Oncol
Rep. 42:1497–506. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhao M, Tang S, Xin J, Wei Y and Liu D:
Reactive oxygen species induce injury of the intestinal epithelium
during hyperoxia. Int J Mol Med. 41:322–330. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bhat AA, Ahmad R, Uppada SPB, Singh AB and
Dhawan P: Claudin-1 promotes TNF-α-induced epithelial-mesenchymal
transition and migration in colorectal adenocarcinoma cells. Exp
Cell Res. 349:119–127. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sayoc-Becerra A, Krishnan M, Fan S,
Jimenez J, Hernandez R, Gibson K, Preciado R, Butt G and McCole DF:
The JAK-Inhibitor tofacitinib rescues human intestinal epithelial
cells and colonoids from cytokine-induced barrier dysfunction.
Inflamm Bowel Dis. 26:407–422. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Catanzaro D, Rancan S, Orso G, Dall'Acqua
S, Brun P, Giron MC, Carrara M, Castagliuolo I, Ragazzi E,
Caparrotta L and Montopoli M: Boswellia serrata preserves
intestinal epithelial barrier from oxidative and inflammatory
damage. PLoS One. 10(e0125375)2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang C, Yan J, Xiao Y, Shen Y, Wang J, Ge
W and Chen Y: Inhibition of Autophagic degradation process
contributes to claudin-2 expression increase and epithelial tight
junction dysfunction in TNF-α treated cell monolayers. Int J Mol
Sci. 18(157)2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Mahalanobish S, Dutta S, Saha S and Sil
PC: Melatonin induced suppression of ER stress and mitochondrial
dysfunction inhibited NLRP3 inflammasome activation in COPD mice.
Food Chem Toxicol. 144(111588)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Friedrich M, Pohin M and Powrie F:
Cytokine networks in the pathophysiology of inflammatory bowel
disease. Immunity. 50:992–1006. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Foerster EG, Mukherjee T, Cabral-Fernandes
L, Rocha JDB, Girardin SE and Philpott DJ: How autophagy controls
the intestinal epithelial barrier. Autophagy. 18:86–103.
2022.PubMed/NCBI View Article : Google Scholar
|
